Literature DB >> 8734827

Second primary cancers following cancers of the kidney and prostate in New South Wales (Australia), 1972-91.

M McCredie1, G J Macfarlane, J Stewart, M Coates.   

Abstract

Data from the New South Wales (NSW) (Australia) Central Cancer Registry for the period 1972-91 were examined to determine the risk of second primary cancers following an initial invasive cancer of the renal parenchyma (ICD-9 code 189.0), renal pelvis (code 189.1), or prostate (code 185). Eligible cases were restricted to those who had survived for at least two months after diagnosis of the first primary cancer. Expected numbers of cancers were obtained by assuming that subjects experienced the same cancer incidence as prevailed in the corresponding general population and applying gender-, age-, and calendar-specific rates to the appropriate person-years at risk. The relative risk (RR) of a second primary cancer was taken to be the ratio of observed to expected numbers of second cancers. Following prostatic cancer, there was an overall deficit of cancers at all sites combined (RR = 0.79, 95 percent confidence interval [CI] = 0.75-0.84), and no site had a significantly raised RR. Taking this into consideration, there appeared to be a reciprocal relationship of increased risk of prostatic cancer (RR = 1.7, CI = 1.2-2.3) following an initial cancer of the renal parenchyma and of renal parenchymal cancer (RR = 1.2, CI = 0.8-1.7) after cancer of the prostate. An increased risk of bladder cancer occurred following renal parenchymal (RR = 3.4, CI = 1.1-8.0, for women only) as well as after renal pelvic cancer (men: RR = 8.7, CI = 5.4-13; women: RR = 39, CI = 26-56). A tobacco-related pattern of excess risk was seen after renal pelvic cancer but not after cancer of the renal parenchyma. These data illustrate that an excess of second primary cancers may reflect shared etiologic factors or increased medical surveillance.

Entities:  

Mesh:

Year:  1996        PMID: 8734827     DOI: 10.1007/bf00052939

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  26 in total

1.  Cigarette smoking and cancers of the renal pelvis and ureter.

Authors:  J K McLaughlin; D T Silverman; A W Hsing; R K Ross; J B Schoenberg; M C Yu; A Stemhagen; C F Lynch; W J Blot; J F Fraumeni
Journal:  Cancer Res       Date:  1992-01-15       Impact factor: 12.701

2.  Analgesics, cigarette smoking, and other risk factors for cancer of the renal pelvis and ureter.

Authors:  R K Ross; A Paganini-Hill; J Landolph; V Gerkins; B E Henderson
Journal:  Cancer Res       Date:  1989-02-15       Impact factor: 12.701

3.  The Copenhagen case-control study of renal pelvis and ureter cancer: role of smoking and occupational exposures.

Authors:  O M Jensen; J B Knudsen; J K McLaughlin; B L Sørensen
Journal:  Int J Cancer       Date:  1988-04-15       Impact factor: 7.396

Review 4.  Familial risk factors for prostate cancer.

Authors:  B S Carter; G D Steinberg; T H Beaty; B Childs; P C Walsh
Journal:  Cancer Surv       Date:  1991

5.  Risk of second malignancy after cancers of the renal parenchyma, renal pelvis, and ureter.

Authors:  A F Kantor; J K McLaughlin; R E Curtis; J T Flannery; J F Fraumeni
Journal:  Cancer       Date:  1986-09-01       Impact factor: 6.860

6.  Summary: multiple primary cancers in Denmark, 1943-80.

Authors:  H H Storm; O M Jensen; M Ewertz; E Lynge; J H Olsen; G Schou; A Osterlind
Journal:  Natl Cancer Inst Monogr       Date:  1985-12

7.  Second cancer following cancer of the urinary system in Connecticut, 1935-82.

Authors:  A F Kantor; J K McLaughlin
Journal:  Natl Cancer Inst Monogr       Date:  1985-12

8.  Second cancer following cancer of the urinary system in Denmark, 1943-80.

Authors:  O M Jensen; J B Knudsen; B L Sørensen
Journal:  Natl Cancer Inst Monogr       Date:  1985-12

9.  Prostate cancer.

Authors:  A S Whittemore
Journal:  Cancer Surv       Date:  1994

10.  Different roles for phenacetin and paracetamol in cancer of the kidney and renal pelvis.

Authors:  M McCredie; J H Stewart; N E Day
Journal:  Int J Cancer       Date:  1993-01-21       Impact factor: 7.396

View more
  11 in total

1.  Cancer registries in epidemiologic research.

Authors:  H H Storm
Journal:  Cancer Causes Control       Date:  1996-05       Impact factor: 2.506

2.  Incidence and prognostic significance of second primary cancers in renal cell carcinoma.

Authors:  Subhankar Chakraborty; Stefano R Tarantolo; Surinder K Batra; Ralph J Hauke
Journal:  Am J Clin Oncol       Date:  2013-04       Impact factor: 2.339

3.  Risk of second primary tumors in men diagnosed with prostate cancer: a population-based cohort study.

Authors:  Elizabeth J Davis; Jennifer L Beebe-Dimmer; Cecilia L Yee; Kathleen A Cooney
Journal:  Cancer       Date:  2014-05-19       Impact factor: 6.860

4.  Second primary malignancies in renal cortical neoplasms: an updated evaluation from a single institution.

Authors:  Katie S Murray; Emily C Zabor; Massimiliano Spaliviero; Paul Russo; Wassim M Bazzi; John E Musser; A Ari Hakimi; Melanie L Bernstein; Guido Dalbagni; Jonathan A Coleman; Helena Furberg
Journal:  World J Urol       Date:  2016-04-22       Impact factor: 4.226

Review 5.  Environmental non-occupational risk factors associated with bladder cancer.

Authors:  J Ferrís; O Berbel; J Alonso-López; J Garcia; J A Ortega
Journal:  Actas Urol Esp       Date:  2013-04-22       Impact factor: 0.994

6.  Is there evidence for a multidisciplinary follow-up after urological cancer? An evaluation of subsequent cancers.

Authors:  M J Mathers; J Zumbe; S Wyler; S Roth; M Gerken; F Hofstädter; T Klotz
Journal:  World J Urol       Date:  2008-04-18       Impact factor: 4.226

7.  [Interdisciplinary oncologic after-care exemplified by second primary tumors after bladder carcinoma].

Authors:  T Klotz; F Hofstädter; M Gerken
Journal:  Urologe A       Date:  2003-06-25       Impact factor: 0.639

8.  Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study.

Authors:  Jae Young Joung; Jiwon Lim; Chang-Mo Oh; Kyu-Won Jung; Hyunsoon Cho; Sung Han Kim; Ho Kyung Seo; Weon Seo Park; Jinsoo Chung; Kang Hyun Lee; Young-Joo Won
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

Review 9.  Is there a role for IGF-1 in the development of second primary cancers?

Authors:  Thurkaa Shanmugalingam; Cecilia Bosco; Anne J Ridley; Mieke Van Hemelrijck
Journal:  Cancer Med       Date:  2016-10-13       Impact factor: 4.452

10.  Quadruple primary urogenital cancers - A case report.

Authors:  Florin-Ioan Elec; Andreea Zaharie; Bogdan-Mihai Ene; Liviu Ghervan
Journal:  Int J Surg Case Rep       Date:  2017-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.